Literature DB >> 27476768

High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis.

Helder Cardoso1, Ana Maria Vale2, Susana Rodrigues2, Regina Gonçalves2, Andreia Albuquerque2, Pedro Pereira2, Susana Lopes2, Marco Silva2, Patrícia Andrade2, Rui Morais2, Rosa Coelho2, Guilherme Macedo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476768     DOI： 10.1016/j.jhep.2016.07.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  39 in total

1.  Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.

Authors:  Ru Han; Clément François; Mondher Toumi
Journal:  Appl Health Econ Health Policy       Date:  2021-01       Impact factor: 2.561

2.  Health-Related Quality of Life in Chronic Hepatitis C.

Authors:  Helder Cardoso; Marco Silva
Journal:  GE Port J Gastroenterol       Date:  2017-01-17

3.  Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma.

Authors:  Xavier Adhoute; Paul Castellani; Marc Bourlière
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-18

4.  Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.

Authors:  Winnie Y Zou; Kati Choi; Jennifer R Kramer; Xian Yu; Yumei Cao; Hashem B El-Serag; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2019-04-30       Impact factor: 3.199

5.  Drug Treatment for Chronic Hepatitis C Infection and Cancer Risk.

Authors:  Marcus-Alexander Wörns; Peter Robert Galle; Stefan Zeuzem; Peter Schirmacher; Michael Manns; Arndt Vogel
Journal:  Dtsch Arztebl Int       Date:  2017-09-04       Impact factor: 5.594

6.  De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.

Authors:  Allison J Kwong; W Ray Kim; Jennifer A Flemming
Journal:  Hepatology       Date:  2018-10       Impact factor: 17.425

Review 7.  Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy.

Authors:  Venkata Rajesh Konjeti; Binu V John
Journal:  Curr Treat Options Gastroenterol       Date:  2018-06

8.  Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.

Authors:  Kenji Ikeda; Yusuke Kawamura; Masahiro Kobayashi; Yoko Kominami; Shunichiro Fujiyama; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2017-09-07       Impact factor: 3.199

9.  The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk.

Authors:  Feng Su; George N Ioannou
Journal:  Curr Hepatol Rep       Date:  2018-09-20

Review 10.  Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.